Cancer Care
CAR T-cell therapy at Methodist provides a 'curative' sense of hope
CAR T-cell therapy involves the extraction of a patient’s T cells for the purpose of reengineering them with chimeric antigen receptors (CARs) that bind to a protein on cancer cells. The infusion of those modified T cells back into the patient’s bloodstream is where the magic happens.
Read Full Story
